Company Filing History:
Years Active: 2001-2006
Title: Saila Antila: Innovator in Pharmaceutical Compositions
Introduction
Saila Antila is a notable inventor based in Helsinki, Finland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for the treatment of congestive heart failure. With a total of 3 patents to his name, Antila's work is recognized for its innovative approach to drug delivery.
Latest Patents
Antila's latest patents include two key inventions related to levosimendan, a drug used in the treatment of congestive heart failure. The first patent, titled "Controlled release peroral compositions of levosimendan," focuses on pharmaceutical compositions that release levosimendan in a controlled manner, minimizing undesired effects. The second patent, "Oral compositions of levosimendan," describes a composition for oral administration that includes a substantially pure crystalline polymorphic form of levosimendan, which is rapidly absorbed from the gastrointestinal tract.
Career Highlights
Saila Antila is currently associated with Orion Corporation, a leading pharmaceutical company. His work at Orion has allowed him to focus on innovative drug formulations that enhance patient outcomes. Antila's research has been pivotal in advancing the understanding and application of levosimendan in clinical settings.
Collaborations
Antila has collaborated with several professionals in his field, including Lasse Lehtonen and Maarit Backman. These collaborations have contributed to the successful development of his patented inventions and have fostered a collaborative environment for innovation.
Conclusion
Saila Antila's contributions to pharmaceutical innovations, particularly in the area of congestive heart failure treatment, highlight his role as a leading inventor in the industry. His patents reflect a commitment to improving drug delivery systems and patient care.